Sylvan Baca is an Assistant Professor of Medicine at Harvard Medical School, a medical oncologist at the Dana-Farber Cancer Institute, and an Associate Member of the Broad Institute. Raised in Albuquerque, NM, Dr. Baca received his undergraduate degree from Stanford University and his MD and PhD from Harvard Medical School. He trained in Internal Medicine at Brigham and Women's Hospital and completed his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. Dr. Baca received his post-doctoral training in cancer epigenetics with Dr. Matthew Freedman at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. He is on faculty at the Dana-Farber Cancer Institute as a Physician and Investigator. In addition to caring for patients, he conducts research at the interface of computational biology and epigenomics to find better ways to treat cancer.
Baca Lab mentees
Shahab Sotudian PhD: Machine learning classifiers of cancer based on cell-free DNA fragmentation Miklós Dióssy PhD: Detecting prostate cancer phenotypes from circulating cell-free epigenomic data Brad Fortunato MS: Analytical methods development for circulating cell-free epigenomics Ziwei Zhang MS: Cistrome-wide association studies of aggressive prostate cancer David Osei-Hwedieh MD PhD: Circulating cell-free epigenomics of bone cancers Karl Semaan MD:Circulating biomarkers for treatment selection in kidney cancer Paulo Da Silva Cordeiro (PhD student): Computational methods development for fragmentomics Jesslyn Goh (MS student): Biomarkers of DNA damage repair deficiency Medha Pandey PhD: cfDNA fragmentomics methods development and benchmarking Chris Dall MD: Epigenetic correlates of resistance to antibody-drug conjugates Alexis Yang (MEng student): Machine learning approaches to predict impact of non-coding variants in cancer
More to come... check back soon!
Former Lab members
Soumya Zacharia MS (currently a software engineer at Beebolt)